 |
 |

Nonsevere Community-Acquired Pneumonia
Correlation Between Cause and Severity or Comorbidity
Miquel Falguera, MD;
Oscar Sacristán, MD;
Antoni Nogués, MD;
Agustín Ruiz-González, MD;
Mercè García, MD;
Anton Manonelles, MD;
Manuel Rubio-Caballero, MD
Arch Intern Med. 2001;161:1866-1872.
Background Community-acquired pneumonia frequently constitutes a nonsevere infection
manageable at home. However, for these low-risk episodes, the epidemiological
features have not been carefully analyzed.
Objectives To determine the cause of nonsevere community-acquired pneumonia and
to investigate if a correlation exists between cause and severity or comorbidity.
Methods During a 3-year period, all patients with nonsevere community-acquired
pneumonia, according to the Pneumonia Patient Outcome Research Team prognostic
classification (patients in groups 1-3), were included in the study. Causes
were investigated through the following procedures: cultures of blood, sputum,
and pleural fluid; serologic tests; and polymerase chain reaction methods
to detect Streptococcus pneumoniae DNA in whole blood
or Mycoplasma pneumoniae and Chlamydia
pneumoniae DNA in throat swab specimens.
Results Of 317 initially included patients, 247 were eligible for the study.
A microbial diagnosis was obtained in 162 patients (66%), and the main pathogens
detected were S pneumoniae (69 patients [28%]), M pneumoniae (40 patients [16%]), and C pneumoniae (28 patients [11%]). For the 58 patients in prognostic
group 1, M pneumoniae was the most prevalent cause,
and atypical microorganisms constituted 40 (69%) of the isolated agents. In
contrast, for patients in prognostic groups 2 and 3, S pneumoniae was the leading agent, and a significant reduction of M pneumoniae cases and a greater presence of other more uncommon pathogens
were observed. The existence of comorbid conditions was not a determining
factor for particular causes.
Conclusions Among low-risk patients with community-acquired pneumonia, there was
a certain correlation between severity and cause. In contrast, the existence
of a comorbidity did not have a predictive causative value.
From the Departments of Internal Medicine (Drs Falguera, Sacristán,
and Rubio-Caballero), Microbiology (Drs Nogués, García, and
Manonelles), and Emergencies (Dr Ruiz-González), Hospital Universitari
Arnau de Vilanova, Lleida, Spain.
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2001;161(15):1929-1930.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Guidelines for the management of adult lower respiratory tract infections
Woodhead et al.
Eur Respir J 2005;26:1138-1180.
ABSTRACT
| FULL TEXT
Quantitative PCR Assay Using Sputum Samples for Rapid Diagnosis of Pneumococcal Pneumonia in Adult Emergency Department Patients
Yang et al.
J. Clin. Microbiol. 2005;43:3221-3226.
ABSTRACT
| FULL TEXT
Management of CAP using a validated risk score
Richeldi et al.
Thorax 2005;60:172-173.
FULL TEXT
Guidelines for Empiric Antimicrobial Prescribing in Community-Acquired Pneumonia
File et al.
Chest 2004;125:1888-1901.
ABSTRACT
| FULL TEXT
Legionnaires' disease: a rational approach to therapy
Roig and Rello
J Antimicrob Chemother 2003;51:1119-1129.
ABSTRACT
| FULL TEXT
Evaluation of a PCR Assay for Detection of Streptococcus pneumoniae in Respiratory and Nonrespiratory Samples from Adults with Community-Acquired Pneumonia
Murdoch et al.
J. Clin. Microbiol. 2003;41:63-66.
ABSTRACT
| FULL TEXT
|